Fairvalue-Calculator Fairvalue-Calculator
EN DE

Zhejiang Int'l Group (000411) Fair Value & Analysis

Healthcare · CN · Market cap 5.4B CNY

Price¥9.60
Fair Value¥19.52
Upside+103.3%
Quality89/100
Evidence: Medium Range ¥14.64 – ¥24.40

Analysis

Zhejiang Int'l Group (000411) currently trades at ¥9.60, while our model-based Fair Value estimate is ¥19.52 — implying the stock looks roughly 103.3% undervalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. It offers chemical drugs, biological products, and Chinese patent medicine. The company was founded in 1950 and is based in Hangzhou, China.

Open the full interactive analysis →

Similar stocks

Eli Lilly and Company (LLY) -64% Johnson & Johnson, (JNJ) -47% AbbVie Inc (ABBV) -71% Roche Holding (ROGN) -96% Merck & Co (MRK) +7% AstraZeneca PLC (A1ZN34) -84%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.